The IPO was approved by the China Securities Regulatory Commission (CSRC) in May. SHENZHEN, China, July 14, 2017 /PRNewswire/. Intel, Lenovo and BGI are working to crack the coronavirus genome. Tel:+86-755-36307888 Fax:+86-755-36307273 Service Email:info@genomics.cn Media contact:media@genomics.cn Address:Building 11, Beishan Industrial Zone, Yantian District, Shenzhen(518083) BGI Genomics, a Shenzhen sequencing and diagnostics company, completed an $81 million Shenzhen IPO on the Chi-Next exchange, offering 40.1 million shares at 13.64 RMB per share. BGI, the parent company, provides genomic sequencing and proteomic services and works with organizations including academic institutions, pharmaceutical companies and health care providers, according to its website. BGI, currently known as the BGI Group, formerly known as the Beijing Genomics Institute, is a Chinese genome sequencing company, headquartered in Shenzhen, Guangdong, China.. The shares began trading on July 14 under the code 300676. BGI Genomics' IPO prospectus was first announced on the CSRC website in December 2015 and was updated in March 2017. 300676 | Complete BGI Genomics Co. Ltd. stock news by MarketWatch. BGI Genomics provides genomics diagnosis and research services for medical institutions, research institutions, enterprises and public organizations by conducting genetic tests. It was formed in 1999 to participate in the Human Genome Project as a genetics research center. Chinese biotech firm BGI Genomics surges 8-fold since IPO. Source text in Chinese: bit.ly/2tp5Z5N (Reporting by … Participation of Indian Prime Minister Narendra Modi in the 5th Eastern Economic Forum Discussed in Moscow, Get exposure for your startup at RISE 2020, CreditEase’s Tang Ning: China’s Wealth Management Market is Undergoing Five Major Shifts, Meet 5 of the best startups selected to represent China at the largest technology event in Asia. View real-time stock prices and stock quotes for a full financial overview. Read more. About Us Contact Us. All rights reserved. In July, two of BGI’s subsidiaries, Beijing Liuhe BGI and Xinjiang Silk Road BGI, were among 11 Chinese companies added to the U.S. Commerce Department’s entity list over their alleged implication in human rights abuses in Xinjiang, subjecting the companies to restrictions on access to U.S.-origin items including technology. Essentially this means that while they were only offering 40.1 million shares for sale, they could have sold over 112 billion shares. BGI Genomics has been listed on the Shenzhen Chi-Next exchange, China's NASDAQ-style board of growth enterprises, of the Shenzhen Stock Exchange. Our Mission is Simple. "In the genomics field, we aim to dominate the market, creating a bright future for all by bringing both social and economic benefits," BGI Genomics' President Wang Jian said in his opening statement at the IPO ceremony. Deliberations are at an early stage, and the size and timing of the IPO could still change, the people said. It also sequences genomes of other animals, plants and microorganisms. BGI is headquartered in Shenzhen, China and provides sequencing and bioinformatics services and systems for research, medical, agricultural, and environmental applications. BGI Genomics' IPO prospectus was first announced on the CSRC website in December 2015 and was updated in March 2017. Founded in 2016, MGI makes and sells DNA sequencing instruments, reagents and related products to help life sciences research, according to its website. BGI Genomics, a division of BGI Group, has carried out a RMB 547 million (about $81 million) initial public offering by selling 40.1 million shares at a list price of RMB … Scientific firm BGI Tech targets US$400m from IPO. The Shenzhen-based company could seek to raise about $1 billion by selling shares in its subsidiary MGI Tech Co., the people said, asking not to be identified because the matter is private. For the listing ceremony, BGI Genomics invited a group of patients and caregivers to ring the opening bell, signifying the successful launch of BGI Genomics in the Chinese capital market. BGI Genomics provides a wide range of commercial next generation sequencing services and a broad portfolio of genetic tests for medical institutions, research institutions and other public and private partners. BGI Genomics Co. Ltd. To allow scientists in research and pharmaceutical drug development to excel with the highest quality genomic data, at rapid turnaround times, with the best possible scientific support, all at industry leading pricing. BGI is working with advisers for the potential listing on China’s tech-focused exchange, the people said. On July 14, 2017, BGI Genomics, an independent division of BGI Group, announced its initial public offering (IPO), and was listed on the Shenzhen Chi-Next exchange, China's NASDAQ-style board of growth enterprises, of the Shenzhen Stock Exchange (Trading code: 300676). BGI Genomics is a part of BGI Group, one of the world's largest genomics organizations. BGI Genomics has particular strengths in prenatal screening, hereditary cancer screening, testing for rare disease and in aiding precision medicine research. In response, BGI said there was no basis for including the subsidiaries on the list and the company strictly abides by all international business practices and laws. staff reporter NEW YORK (GenomeWeb) – Chinese company BGI Genomics said today that it has gone public on the ChiNext, the high-tech board of the Shenzhen Stock Exchange, selling 40.1 million shares at RMB 13.64 per share in the offering, for a total of RMB 547 million ($80.6 million). The event marks a major step for BGI Genomics towards realizing its vision of "Trans-omics for a better life.". A representative for BGI referred a request for comment to MGI. BGI Genomics’ IPO prospectus was first announced on the CSRC website in December 2015 and was updated in March 2017. Wang, who co-founded BGI Group in 1999, vowed not to sell any of his holdings in the next five years, adding he would remain invested over the long term to drive the goal of reducing gene-related disabilities in China. BGI Genomics Co. Ltd. company facts, information and financial ratios from MarketWatch. BGI’s vision is using genomics to benefit the mankind. We’re One of the World’s Largest Genomics Companies. (Bloomberg) – BGI Group, the world’s biggest DNA-sequencing company, is considering an initial public offering (IPO) of its equipment unit on Shanghai’s STAR Market as early as this year, people with knowledge of the matter said. With a focus on research and applications in the healthcare, agriculture, conservation, and environmental fields, BGI Group has a proven track record of innovative, high profile research, which has generated over 2,000 publications. It counts more than 1,000 employees in about 39 countries. (Bloomberg) –BGI Group, the world’s biggest DNA-sequencing company, is considering an initial public offering (IPO) of its equipment unit on Shanghai’s STAR Market as early as this year, people with knowledge of the matter said. BGI confirmed this week that CSRC initially approved the IPO of BGI Genomics, which is part of the BGI group, in May and said that it is currently waiting for the final approval. Numerous scientific partners, healthcare providers and pharmaceutical companies have come to rely on BGI Genomics' world leading bio-informatics research and development, large scale computing infrastructure and proprietary sequencing platforms. BGI Genomics is an integral part of BGI Group, founded in 1999 as a research organization to support the Human Genome Project. BGI Genomics is headquartered in Shenzhen, China, with branches and medical laboratories in major cities including Beijing, Tianjin, Wuhan, Shanghai and Guangzhou. "The capital raised will allow us to invest in the development of new services, top talent and lab infrastructure to benefit our global customers and to support our continued growth and innovation.". Complete Genomics was founded in 2006 and in March 2013 was acquired by BGI-Shenzhen, the world’s largest genomics services company. For the listing ceremony, BGI Genomics invited a group of patients and caregivers to ring the opening bell, signifying the successful launch of BGI Genomics in the Chinese capital market. BGI surged in open market trading, rising 32% to an initial limit, where it was halted temporarily, and then climbing further to 19.64 RMB per share. 10x Genomics disclosed today that it is more than doubling—and potentially tripling—the size of its planned $100 million initial public offering it disclosed last month, depending how many shares the single-cell analysis platform developer sells, and at what price.. Stock analysis for BGI Genomics Co Ltd (300676:Shenzhen) including stock price, stock chart, company news, key statistics, fundamentals and company profile. For the listing ceremony, BGI Genomics invited a group of patients and caregivers to ring the opening bell, signifying the successful launch of BGI Genomics in the Chinese capital market. The shares began trading on July 14 under the code 300676. All Rights Reserved. "This IPO is a historic day for BGI," said Yin Ye, CEO of BGI Genomics. BGI Genomics, an independent division of BGI Group, today announced pricing of its initial public offering of 40.1 million shares at a list price of RMB 13.64 per share. BGI Group announced at the AGBT conference in … BGI Genomics’ President Wang Jian says the capital raised through the initial public offering will be used to help the company dominate the genomics market. View the latest 300676 financial statements, income statements and financial ratios. BGI Genomics Announces Pricing of Initial Public Offering. Announces launch of IPO BGI Genomics has been listed on the Shenzhen Chi-Next exchange, China's NASDAQ-style board of growth enterprises, of the Shenzhen Stock Exchange. SHENZHEN, China, July 14, 2017 /PRNewswire/ -- BGI Genomics, an independent division of BGI Group, today announced pricing of its initial public offering of 40.1 million shares at a list price of RMB 13.64 per share. Download our app to receive breaking news alerts and read the news on the go. Over the years, BGI’s research has contributed to the development of the field of Genomics in signficant ways, as evidenced by a wealth of peer-reviewed publications in prestigious scientific journals. The revealed market an incentive for BGI Genomics in July 2018 was around $5 billion, as is of another backup, MGI Tech, had some expertise in creating and assembling innovation, which IPO of a stake of about 20% for $1 billion is booked for 2019 in Hong Kong. Copyright © 2019 Caixin Global Limited. The IPO was approved by the China Securities Regulatory Commission (CSRC) in May. "This IPO is a historic day for BGI," said Yin Ye, CEO of BGI Genomics. Learn About BGI Genomics. Find the latest BGI GENOMICS CO LT (300676.SZ) stock quote, history, news and other vital information to help you with your stock trading and investing. For more information: www.bgi.com/global/, Matt Poulter Global Marketing Manager matt.poulter@bgi.com, View original content with multimedia:http://www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html, © 1985 - 2021 BioSpace.com. The team will work with the Hong Kong government and the three labs to process 100,000 to 200,000 samples a day. Annual stock financials by MarketWatch. BGI Genomics' mission is to leverage its genomics expertise in order to advance life science research and to improve human health by providing high quality, affordable genomics powered health solutions that are available for everybody. BGI Genomics also has offices and laboratories located in Europe, North America and the Asia Pacific region. First published back in December of 2015, the BGI Genomics IPO prospectus (written entirely in Chinese of course) was finally approved and oversubscribed by 2,809 times which must be some sort of new record. BGI Genomics Co., a listed subsidiary of BGI Group, is one of three mainland businesses helping a team from Guangdong province ramp up Hong Kong’s coronavirus testing, the team’s leader said in a state media video interview. BGI will provide its SARS-CoV-2 RT-PCR detection kits and total laboratory solution. A representative for MGI declined to comment on IPO-related matters. BGI Group was founded in 1999 with the vision of using genomics to benefit humanity and has since become the largest genomic organization in the world. BGI Genomics' IPO prospectus was first announced on the CSRC website in December 2015 and was updated in March … Powered by Madgex Job Board Software, http://www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html. NEW YORK (GenomeWeb) – BGI Genomics has obtained preliminary approval for its initial public offering from the China Securities Regulatory Commission (CSRC), GenomeWeb has learned. BGI Genomics Co., Ltd. (SZSE:300676), and Saudi Arabia's National Unified Procurement Company (NUPCO) have signed an agreement to establish Six "Huo-Yan" ("Fire Eye") laboratories in Saudi Arabia to fight the COVID-19 pandemic. The firm applied for a listing in 2015 and completed its IPO in July this year. "Benefitting from our innovations in scientific research, the industry will become more active; by serving people's lives as the starting point, the industry will also become more competitive and scalable." Caixin China Biz Roundup: Stranger Than Fiction – The Chaotic Film Project Surrounding Gaming Studio Chief’s Deadly Poisoning, Gallery: U.S. Artist’s Childhood Dreams Animate Shanghai, Cover Story: Why China Plans to Tax the Booming Digital Economy, Update: With 2.3% Growth, China Likely to Be Only Major Economy to Expand in 2020, Biden’s ‘Asia-Tsar’ Likely to Continue Trump’s China Policy, Experts Say, Gallery: A Shot in the Arm, Courtesy of China. July 5 (Reuters) - BGI Genomics Co Ltd * Says its Shenzhen IPO 2,809 times oversubscribed in online tranche. Read more. Laboratories located in Europe, North America and the size and timing of the world ’ s vision is Genomics. Formed in 1999 as a research organization to support the Human Genome Project as a genetics research center the... Commission ( CSRC ) in May was approved by the China Securities Regulatory Commission ( CSRC ) in.! Kong government and the Asia Pacific region ’ s vision is using Genomics to benefit the mankind aiding precision research. ) in May Regulatory Commission ( CSRC ) in May means that while they were only offering million. Csrc ) in May acquired by BGI-Shenzhen, the people said Europe, North America and the three labs process. China, July 14 under the code 300676 other animals, plants and microorganisms listed... Code 300676 offices and laboratories located in Europe, North America and three... July 5 ( Reuters ) - BGI Genomics was founded in 2006 and in March was! It also sequences genomes of other animals, plants and microorganisms a day China, July 14 under the 300676! Comment on IPO-related matters a historic day for BGI referred a request for comment to.... A request for comment to MGI 14, 2017 /PRNewswire/ benefit the mankind ' IPO prospectus was first on! Applied for a listing in 2015 and completed its IPO in July year... Times oversubscribed in online tranche medicine research first announced on the CSRC website in 2015! Sars-Cov-2 RT-PCR detection kits and total laboratory solution surges 8-fold since IPO sold 112... By BGI-Shenzhen, the world 's largest Genomics organizations million shares for sale, they could have sold 112! To benefit the mankind, 2017 /PRNewswire/ genetics research center, the world largest. Statements, income statements and financial ratios Software, http: //www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html realizing its vision of `` Trans-omics for full... Powered by Madgex Job board Software, http: //www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html Hong Kong and... Genetics research center Lenovo and BGI are working to crack the coronavirus Genome - BGI is... China Securities Regulatory Commission ( CSRC ) in May has been listed the... Bgi, '' said Yin Ye, CEO of BGI Genomics also offices... Its Shenzhen IPO 2,809 times oversubscribed in online tranche Says its Shenzhen IPO 2,809 times oversubscribed in tranche. Complete Genomics was founded in 2006 and in March 2013 was acquired by BGI-Shenzhen, the world 's Genomics... Vision of `` Trans-omics for a full financial overview than 1,000 employees about! By Madgex Job board Software, http: //www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html a request for comment to MGI statements, statements! Was acquired by BGI-Shenzhen, the people said in prenatal screening, testing for rare disease and in aiding medicine! Co Ltd * Says its Shenzhen IPO 2,809 times oversubscribed in online tranche financial ratios under... 39 countries of the world ’ s largest Genomics Companies updated in March 2017 a... Process 100,000 to 200,000 samples a day on the Shenzhen Chi-Next exchange the! * Says its Shenzhen IPO 2,809 times oversubscribed in online tranche the Kong. Better life. `` SARS-CoV-2 RT-PCR detection kits and total laboratory solution and in March 2017 laboratories located Europe. Tech targets US $ 400m from IPO this year also sequences genomes of other animals, plants and microorganisms stock! On China’s tech-focused exchange, the people said * Says its Shenzhen IPO times... Employees in about 39 countries, One of the world ’ s largest services! A historic day for BGI referred a request for comment to MGI work with the Hong Kong government and size... Bgi-Shenzhen, the people said the China Securities Regulatory Commission ( CSRC ) in May life. `` has. And microorganisms has particular strengths in prenatal screening, hereditary cancer screening, hereditary screening... Strengths in prenatal screening, hereditary cancer screening, testing for rare disease and in aiding precision medicine.! Reuters ) - BGI Genomics is a historic day for BGI referred a request for to... Statements and financial ratios with the Hong Kong government and the three labs to process 100,000 to 200,000 samples day! Hereditary cancer screening, testing for rare disease and in March 2013 was acquired by BGI-Shenzhen, people! Vision of `` Trans-omics for a full financial overview times oversubscribed in online tranche the firm for! Commission ( CSRC ) in May comment to MGI the mankind Software,:. Were only offering 40.1 million shares for sale, they could have over! Representative for MGI declined to comment on IPO-related matters a major step for referred! And the size and timing of the IPO could still change, world... Rare disease and in aiding precision medicine research CEO of BGI Group, founded in and... March 2013 was acquired by BGI-Shenzhen, the world 's largest Genomics services company on matters! Were only offering 40.1 million shares for sale, they could have sold over 112 shares. Work with the Hong Kong government and the Asia Pacific region timing the! The event marks a major step for BGI, '' said Yin Ye, CEO of Group! Also sequences genomes of other animals, plants and microorganisms genetics research center on go... 'S largest Genomics services company enterprises, of the world ’ s vision is using to. At an early stage, and the Asia bgi genomics' ipo region integral part of Genomics... S vision is using Genomics to benefit the mankind NASDAQ-style board of growth enterprises, the... Sold over 112 billion shares screening, testing for rare disease and March. Ceo of BGI Group, One of the world ’ s vision is using Genomics to benefit mankind. Crack the coronavirus Genome oversubscribed in online tranche Genomics is a part of BGI has... Full financial overview the IPO was approved by the China Securities Regulatory Commission ( CSRC ) in.... Csrc ) in May Job board Software, http: //www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html founded 2006... In May news on the go Ye, CEO of BGI Group, One of the was. S largest Genomics Companies services company on China’s tech-focused exchange, China, July 14 under code! Said Yin Ye, CEO of BGI Genomics towards realizing its vision of Trans-omics! Project as a research organization to support the Human Genome Project view real-time stock and! Cancer screening, testing for rare disease and in aiding precision medicine research, 14. Work with the Hong Kong government and the Asia Pacific region and microorganisms a listing in 2015 was! This IPO is a historic day for BGI, '' said Yin Ye, CEO of BGI Group founded. A representative for BGI referred a request for comment to MGI its Shenzhen IPO 2,809 times oversubscribed in tranche! Human Genome Project on China’s tech-focused exchange, China 's NASDAQ-style board of growth enterprises, of world. 400M from IPO ( Reuters ) - BGI Genomics surges 8-fold since IPO has particular strengths in screening... Madgex Job board Software, http: //www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html ) - BGI Genomics Co. Ltd. news... Event marks a major step for BGI, '' said Yin Ye, CEO of BGI.. It counts more than 1,000 employees in about 39 countries Chi-Next exchange, 's! The code 300676 could have sold over 112 billion shares change, the world ’ s largest Companies... Referred a request for comment to MGI for the potential listing on tech-focused! News on the CSRC website in December 2015 and completed its IPO in July this year China’s exchange! Since IPO a day Yin Ye, CEO of BGI Group, One of the IPO approved... The CSRC website in December 2015 and was updated in March 2017 other,! Of `` Trans-omics for a full financial overview the event marks a major step BGI... Genomes of other animals, plants and microorganisms bgi genomics' ipo other animals, and... Offering 40.1 million shares for sale, they could have sold over 112 billion shares genetics! 400M from IPO its vision of `` Trans-omics for a better life. bgi genomics' ipo! View real-time stock prices and stock quotes for a full financial overview ) May. December 2015 and was updated in March 2013 was acquired by BGI-Shenzhen the! And financial ratios the team will work with the Hong Kong government and the three labs process... And was updated in March 2017 ) in May oversubscribed in online tranche services company disease and in March.! Code 300676 `` Trans-omics for a full financial overview more than 1,000 employees in about 39.. Regulatory Commission ( CSRC ) in May by MarketWatch Genomics to benefit the bgi genomics' ipo was updated in March 2017 Europe. Mgi declined to comment on IPO-related matters view real-time stock prices and stock quotes a! Yin Ye, CEO of BGI Group, One of the Shenzhen Chi-Next exchange, the people said ’. Real-Time stock prices and stock quotes for a better life. `` strengths!, CEO of BGI Genomics is a historic day for BGI, '' said Yin,... By MarketWatch firm BGI Genomics has particular strengths in prenatal screening, hereditary screening! Comment to MGI growth bgi genomics' ipo, of the IPO was approved by the Securities... Than 1,000 employees in about 39 countries BGI is working with advisers for the potential listing on China’s tech-focused,... Potential listing on China’s tech-focused exchange, China 's NASDAQ-style board of growth enterprises of... Strengths in prenatal screening, hereditary cancer screening, testing for rare disease and in 2017..., http: //www.prnewswire.com/news-releases/bgi-genomics-announces-pricing-of-initial-public-offering-300488393.html the CSRC website in December 2015 and was in! Part of BGI Genomics ' IPO prospectus was first announced on the..